<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Diğer Yayınlar Koleksiyonu</title>
<link href="https://hdl.handle.net/20.500.11857/545" rel="alternate"/>
<subtitle/>
<id>https://hdl.handle.net/20.500.11857/545</id>
<updated>2026-06-02T17:51:39Z</updated>
<dc:date>2026-06-02T17:51:39Z</dc:date>
<entry>
<title>Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study (Oct, 10.1007/s10266-021-00667-4, 2021)</title>
<link href="https://hdl.handle.net/20.500.11857/3689" rel="alternate"/>
<author>
<name>Özdal Zincir, Özge</name>
</author>
<author>
<name>Özdal, Umut</name>
</author>
<author>
<name>Ünlü, Özge</name>
</author>
<author>
<name>Demirci, Mehmet</name>
</author>
<author>
<name>Katiboğlu, Ahmet Bülent</name>
</author>
<author>
<name>Egil, Edibe</name>
</author>
<author>
<name>Altan Sallı, Gülay</name>
</author>
<id>https://hdl.handle.net/20.500.11857/3689</id>
<updated>2023-01-28T12:23:28Z</updated>
<published>2021-01-01T00:00:00Z</published>
<summary type="text">Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study (Oct, 10.1007/s10266-021-00667-4, 2021)
Özdal Zincir, Özge; Özdal, Umut; Ünlü, Özge; Demirci, Mehmet; Katiboğlu, Ahmet Bülent; Egil, Edibe; Altan Sallı, Gülay
[Abstract Not Available]
</summary>
<dc:date>2021-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Prognostic implications of hypochloremia in heart failure patients with a reduced glomerular filtration rate</title>
<link href="https://hdl.handle.net/20.500.11857/3635" rel="alternate"/>
<author>
<name>Güvenç, Rengin Çetin</name>
</author>
<author>
<name>Yılmaz, M. B.</name>
</author>
<id>https://hdl.handle.net/20.500.11857/3635</id>
<updated>2023-01-28T12:23:24Z</updated>
<published>2021-01-01T00:00:00Z</published>
<summary type="text">Prognostic implications of hypochloremia in heart failure patients with a reduced glomerular filtration rate
Güvenç, Rengin Çetin; Yılmaz, M. B.
[Abstract Not Available]
</summary>
<dc:date>2021-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>The effectiveness of Glasgow-Blatchford Score in early risk assessment of hemodialysis patients</title>
<link href="https://hdl.handle.net/20.500.11857/3055" rel="alternate"/>
<author>
<name>Satılmış, Dilay</name>
</author>
<author>
<name>Yavuz, Burcu Genç</name>
</author>
<author>
<name>Güven, Oya</name>
</author>
<author>
<name>Güven, Ramazan</name>
</author>
<author>
<name>Cander, Başar</name>
</author>
<id>https://hdl.handle.net/20.500.11857/3055</id>
<updated>2023-01-28T12:23:11Z</updated>
<published>2021-01-01T00:00:00Z</published>
<summary type="text">The effectiveness of Glasgow-Blatchford Score in early risk assessment of hemodialysis patients
Satılmış, Dilay; Yavuz, Burcu Genç; Güven, Oya; Güven, Ramazan; Cander, Başar
In the emergency departments (ED), the incidence of admission is increasing gradually due to gastrointestinal system (GIS) complications of hemodialysis (HD) patients. With this increasing number of patients, there are many classification systems developed in early risk assessment before endoscopy. In this study, we aimed to evaluate the Glasgow-Blatchford Score's (GBS) effectiveness in HD patients with suspected GIS hemorrhage in the ED.The files of 169 patients who received HD treatment were retrospectively reviewed. 64 patients who were examined and treated for reasons other than GIS hemorrhage in the ED were excluded, and the files of a total of 105 were analyzed retrospectively. The demographic characteristics and laboratory values of the patients were recorded from the patient files. When the patients were evaluated according to GBS parameters, a significant difference was found between the two groups in terms of pulse pressure, systolic blood pressure, hemoglobin value, melena, and accompanying comorbid diseases (p &lt; 0.05). Of the 16 patients who presented to the ED due to syncope, 2 were in the GIS hemorrhage (+) group, and 14 patients were in the control group. In this study, we aimed to show that the increase in the number of admissions in the ED due to complications secondary to HD treatment and the accompanying serious changes in laboratory parameters may cause misleading results in patients with suspected GIS hemorrhage, and it is necessary to plan comprehensive and multi-center studies on new alternative scoring systems to GBS in specific patient groups such as HD patients.
</summary>
<dc:date>2021-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Efficacy of Octyl-2-Cyanoacrylate in Type I Tympanoplasty</title>
<link href="https://hdl.handle.net/20.500.11857/2991" rel="alternate"/>
<author>
<name>Gedikli, Orhan</name>
</author>
<author>
<name>Eren, Sabri Baki</name>
</author>
<author>
<name>Kahya, Volkan</name>
</author>
<author>
<name>Korkut, Arzu Yasemin</name>
</author>
<author>
<name>Teker, Ayşenur Meriç</name>
</author>
<author>
<name>Coşkun, Berna Uslu</name>
</author>
<id>https://hdl.handle.net/20.500.11857/2991</id>
<updated>2023-01-28T12:17:38Z</updated>
<published>2011-01-01T00:00:00Z</published>
<summary type="text">Efficacy of Octyl-2-Cyanoacrylate in Type I Tympanoplasty
Gedikli, Orhan; Eren, Sabri Baki; Kahya, Volkan; Korkut, Arzu Yasemin; Teker, Ayşenur Meriç; Coşkun, Berna Uslu
Objective: To evaluate the safety and efficacy of octyl-2-cyanoacrylate for type I tympanoplasty. Methods: This study involved 23 patients (14 females and 9 males) with chronic otitis media who underwent type I tympanoplasty. During surgery, the temporal fascia is placed underlying the eardrum remnant, and octyl-2-cyanoacrylate was dropped over the temporal fascia. The mean air-bone gap (ABG) at the 4 frequencies (500, 1000, 2000, and 4000) was calculated for each patient before and after surgery. These data were compared by Student t test. Results: The mean follow-up was 10 months (range, 6-12 mo). Successful tympanic membrane grafting occurred in 21 patients (91.3%). Graft failure was seen in 2 patients. The mean preoperative ABG of the 23 patients was 19.3 (SD, 5.7) dB, and the postoperative ABG improved to a mean value of 8.2 (SD, 5.9) dB (P &lt;= 0.0001). Conclusions: Octyl-2-cyanoacrylate is effective and safe in using as a compound on temporalis muscle fascia in type I tympanoplasty and can be used more widely in tympanoplasty.
11th International Congress on Cleft Lip and Palate and Related Craniofacial Anomalies -- SEP 10-13, 2009 -- Fortaleza, BRAZIL --
</summary>
<dc:date>2011-01-01T00:00:00Z</dc:date>
</entry>
</feed>
